[CAR-T cells and bispecific antibodies: An update on these major therapeutic advances]

Bull Cancer. 2021 Oct;108(10S):S1-S3. doi: 10.1016/j.bulcan.2021.11.006.
[Article in French]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Bispecific / therapeutic use*
  • Genetic Introgression
  • Hematologic Neoplasms / therapy*
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Humans
  • Immunity, Cellular
  • Immunologic Surveillance*
  • Immunotherapy, Adoptive* / adverse effects
  • Immunotherapy, Adoptive* / economics
  • Immunotherapy, Adoptive* / methods
  • Receptors, Chimeric Antigen*

Substances

  • Antibodies, Bispecific
  • Receptors, Chimeric Antigen